pphmtoolong: That's bad news and I'm sorry. Sincerely. I just lost a buddy last week from GMB, about two years from diagnosis after several surgeries, etc. Try to see if there is any chance of getting Cotara as part of a study if there are any ongoing. I think the Univ of Pittsburg was one site that was testing it. I haven't checked the company's web site lately, but I'd check on it. If I were diagnosed with GMB I'd want to get Cotara. At least there is one success story out there, a guy named Phil whose still kicking as far as I know after more than 5 years after Cotara. It is a very tough diagnosis. Our prayers of course. I wish the company could move this along faster. With so few treatment options even a marginally better drug would get approved if they'd just get on with it. It's frustrating because there are many people who could benefit if Cotara was employed EARLY after the initial diagnosis....not after surgery and relapse, etc.
News 
Market Data 
Discover 
AI
